Oligometastatic renal cell carcinoma (OM-RCC) refers to patients who have limited (typically
up to 5) metastatic lesions. Although management principles may overlap, OM-RCC is …

Nephrectomy After Complete Response to Immune Checkpoint Inhibitors for Metastatic Renal
Cell Carcinoma: A New Surgical Challenge? - Abstract - Europe PMC Sign in | Create an …

Background The management of metastatic renal cell carcinoma (mRCC) has evolved
rapidly, and results from the Cancer du Rein Metastatique Nephrectomie et …

Background Inferior vena cava tumor thrombus (IVC-TT) is a rare yet deadly sequel of renal
cell carcinoma (RCC) with limited treatment options. The standard treatment is extirpative …

Purpose: Data supporting complete metastasectomy of metastatic renal cell carcinoma were
derived primarily from the era of cytokine therapy. Whether complete metastasectomy …

Abstract Background Immune checkpoint inhibitors (ICIs) are now a mainstay of metastatic
renal cell carcinoma (RCC) management with five current Food and Drug Administration …

Purpose: Rocapuldencel-T is an autologous immunotherapy prepared from mature
monocyte-derived dendritic cells (DC), coelectroporated with amplified tumor RNA plus …

Context The current role of cytoreductive nephrectomy (CN) is controversial. Objective
Review of the available evidence about criteria defining CN optimal candidates. Evidence …

Secondary tumours to the thyroid gland are uncommon and often incidentally discovered on
imaging. Symptomatic patients often present with a neck mass. Collision tumours of …

Kidney transplant recipients (KTRs) are at increased risk of developing renal cell carcinoma
(RCC). The cancer can be encountered at different steps in the transplant process. RCC …